Anwar N, Kingma D W, Bloch A R, Mourad M, Raffeld M, Franklin J, Magrath I, el Bolkainy N, Jaffe E S
National Cancer Institute, Cairo, Egypt.
Cancer. 1995 Oct 1;76(7):1245-52. doi: 10.1002/1097-0142(19951001)76:7<1245::aid-cncr2820760723>3.0.co;2-d.
Epstein-Barr virus (EBV) is associated with many human neoplasms, including Burkitt's lymphoma (BL). Endemic BL in central Africa is more often EBV-associated than BL in the United States, where seroconversion for EBV occurs somewhat later than in Africa. Therefore, the EBV association rate in BL may correlate more with the socioeconomic status of the population studied, which influences the age of EBV seroconversion, than with such factors as malaria, which may relate to the overall higher incidence rate in endemic regions.
Forty-one patients with BL in Egypt, which differs both climatically and racially from central African countries (i.e., Kenya, Uganda) where BL is endemic, were analyzed. All biopsies were evaluated for EBV-encoded RNAs (EBER1) by RNA in situ hybridization, analyzed for p53 protein expression using the monoclonal antibody D07, and immunophenotyped using a panel of monoclonal antibodies that included L26 (CD20), Leu 22 (CD43), and A6 (CD45RO). Twelve cases were evaluable for EBV subtype by polymerase chain reaction with EBV-specific primers.
The median age at diagnosis was 9 years (range, 2-22 years). The biopsy site was extranodal in 29 patients and nodal in 12 patients. All 41 cases were documented as B-cell neoplasms. A hybridization signal for EBER1 RNA was identified in greater than 95% of the neoplastic cells in 30 of 41 cases (73%), whereas no signal was observed in 11 cases (27%). Epstein-Barr virus subtype 1 was found in 10 patients, subtype 2 in two patients. Immunostaining for p53 was observed in greater than 5% of the neoplastic cells in 9 of 37 cases (24%). No significant correlation was observed between EBV positivity and sex, biopsy site, or p53 immunostaining.
The prevalence of EBV in BL from Egypt is slightly lower than in BL in endemic regions, but significantly higher than in sporadic BL. Epstein-Barr virus positivity probably reflects the socioeconomic status of the patient population, and age at seroconversion. The prevalence of EBV subtype 1 suggests that immunodeficiency does not play a role in Egyptian Burkitt's lymphoma, in contrast to endemic Burkitt's lymphoma, in which holoendemic malaria is thought to contribute to immunodeficiency, a higher incidence rate, and the observed prevalence of subtype 2.
爱泼斯坦-巴尔病毒(EBV)与许多人类肿瘤相关,包括伯基特淋巴瘤(BL)。非洲中部的地方性BL比美国的BL更常与EBV相关,在美国,EBV血清转化发生的时间比非洲稍晚。因此,BL中EBV的关联率可能更多地与所研究人群的社会经济状况相关,社会经济状况会影响EBV血清转化的年龄,而不是与疟疾等因素相关,疟疾可能与地方性地区总体较高的发病率有关。
对41例埃及BL患者进行了分析,埃及在气候和种族上与BL为地方性疾病的非洲中部国家(即肯尼亚、乌干达)不同。所有活检标本均通过RNA原位杂交评估EBV编码RNA(EBER1),使用单克隆抗体D07分析p53蛋白表达,并使用一组包括L26(CD20)、Leu 22(CD43)和A6(CD45RO)的单克隆抗体进行免疫表型分析。12例病例可通过使用EBV特异性引物的聚合酶链反应评估EBV亚型。
诊断时的中位年龄为9岁(范围为2至22岁)。29例患者的活检部位为结外,12例为结内。所有41例病例均被记录为B细胞肿瘤。41例中的30例(73%)在超过95%的肿瘤细胞中检测到EBER1 RNA杂交信号,而11例(27%)未观察到信号。10例患者中发现EBV 1型,2例患者中发现EBV 2型。37例中的9例(24%)在超过5%的肿瘤细胞中观察到p53免疫染色。未观察到EBV阳性与性别、活检部位或p53免疫染色之间存在显著相关性。
埃及BL中EBV的患病率略低于地方性地区的BL,但显著高于散发性BL。EBV阳性可能反映了患者人群的社会经济状况以及血清转化的年龄。EBV 1型的患病率表明免疫缺陷在埃及伯基特淋巴瘤中不起作用,这与地方性伯基特淋巴瘤不同,在地方性伯基特淋巴瘤中,全地方性疟疾被认为会导致免疫缺陷、更高的发病率以及观察到的2型患病率。